Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-07-25
1995-09-05
Prescott, Arthur C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514262, 544265, 544276, A61K 3152
Patent
active
054479398
ABSTRACT:
Disclosed herein are methods directed generally to the control of neural activity and to the treatment of neural disorders. More particularly, the present invention is directed to methods for the modification of mammalian neural activity through the administration of carbon monoxide dependent guanylyl cyclase modulating purine derivatives. The methods of the present invention may be used to affect a variety of neurological activities and to therapeutically or prophylactically treat a wide variety of neurodegenerative and neurological disorders.
REFERENCES:
patent: 3321369 (1967-05-01), Glasky et al.
patent: 3438968 (1969-04-01), Glasky
patent: 4221910 (1980-09-01), Sorolla
patent: 4952693 (1990-08-01), Sircan et al.
patent: 5091432 (1992-02-01), Glasky
Sylvain Lehmann et al., "Neurite outgrowth of neurons . . . guanidine group", Neuroscience Letters, 1993, 152:57-60, Elsevier Sci. Pub. Ireland Ltd.
Marcia Barinaga, "Carbon Monoxide: Killer to Brain Messenger in One Step", Science, 15 Jan. 1993, 259:309.
Ajay Verma et al., "Carbon Monoxide: A Putative Neural Messenger", Science, 15 Jan. 1993, 259:381-384.
Min Zhuo et al., "Nitric Oxide and Carbon Monoxide . . . Hippocampus", Science, 25 Jun. 1993, 260:1946-1950.
.ANG.ke Seiger et al., "Intracranial infusion of p urified nerve . . . strategy" Behavioral Brain Research, 1993, 57:255-261.
Atsumi Nitta et al., "Effects of oral administration . . . in basal fore-brain-lesioned rats", Eur. Journal of Pharmacology, 1993, 250:23-30.
M. H. Tuszynski & F. H. Gage, "Neurotrophic Factors and Neuronal Loss", Ch. 25, Alzheimer Disease, R. D. Terry et al., eds., 1994, 405-427, Raven Press, N.Y.
R. D. Hawkins et al., "Nitric Oxide and Carbon Monoxide . . . Long-Term Potentiation," Journal of Neurobiology, 1994, 25:6, pp. 652-665.
S. H. Snyder, "NO and CO: The Body's Unprecedented Signaling Molecules," 1995 Yearbook of Sci. & the Future, Encyc. Brit., pp. 96-99.
Glasky Alvin J.
Rathbone Michael P.
LandOfFree
Carbon monoxide dependent guanylyl cyclase modifiers and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbon monoxide dependent guanylyl cyclase modifiers and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbon monoxide dependent guanylyl cyclase modifiers and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-472954